80
S. PraSaD et al.
or on a Waters Micromass ZQ 2000 ESCi equipped with
MassLynx version 4.1. Matrix assisted laser desorption
ionisation (MALDI) was performed on a Applied Bio-
systems Voyager DE STR MALDI (reflectron mode)
with the matrix trans-2-[3-(4-tert-butylphenyl)-2-methyl-
2-propenylidene]-malononitrile. High resolution ESI
(HR-MS) mass spectrometry was performed on a Thermo
Linear Quadropole Ion Trap Fourier Transform Ion
Cyclotron Resonance (LQT FT Ultra) mass spectrometer
in electrospray mode with a 7 T superconducting magnet
at the BMSF, Analytical Centre at the University of New
South Wales. Melting points were recorded using a Mel-
Temp II melting point apparatus and are uncorrected.
standard. Cyclic Voltammetry was performed on either
a Electrochemical Analyzer BAS100B (BASi) utilizing
BAS100W software or on aAutolab Potentiostat PGSTAT
12 equipped with GPES version 4.9. Surface modi-
fied electrodes were analyzed in a solution of 100 mM
phosphate buffer (pH 7.0) with 200 mM potassium chlo-
ride and 1 mM ferrocyanide with Ag|AgCl reference and
platinum counter electrodes. Each sample was deoxygen-
ated by bubbling dry nitrogen for 5 min prior to elec-
trochemical analysis. X-ray Crystallography work in this
research was undertaken on the macromolecular crystal-
lography beamline at the Australian Synchrotron, Victo-
ria, Australia. Surface analysis by X-ray photoelectron
spectroscopy (XPS) was performed on a VG ESCALAB
220-IXL imaging XPS microscope with an Al Ka X-ray
(1486.6 eV) anode source. Surface UV-vis absorption
measurements were made using a Cary 5 UV-vis-NIR fit-
ted with a diffuse reflectance apparatus. The 5,10,15,20-
tetrakis[(4-trimethylsilyl)ethynyl-phenyl]porphyrin1was
synthesized according to literature procedure [25]. UV-
vis (CH2Cl2): λmax, nm (log ε) 422 (5.65), 516 (4.38),
as fine purple crystals (347 mg, 97%), mp > 300 °C. UV-
vis (CH2Cl2): λmax, nm (log ε) 431 (5.74), 562 (4.29), 603
(4.27). 1H NMR (300 MHz, CDCl3, Me4Si): δH, ppm 0.39
(36H, s, Si(CH3)3), 7.93 and 8.25 (16H, ABq, J = 8.2 Hz,
Ph), 9.19 (8H, s, satellites, 4J1H-Sn = 14.8 Hz, pyrrole-H).
119Sn NMR (149 MHz, CDCl3, Me4Sn): δSn, ppm -590.08
(Sn). FTIR (KBr): ν, cm-1 2956 (m), 2898 (w), 2157 (s),
1499 (m), 1249 (s), 1030 (s), 864 (s). MS (MALDI):
m/z 1116.26 (calcd. for [M - 2Cl]+ 1116.29). HR-MS
(FT-ESI): m/z 1147.3091 (calcd. for C65H63N4OSi4Sn:
[M - 2Cl + OCH3]+ 1147.2836), 1133.2935 (calcd. for
C64H61N4OSi4Sn: [M - 2Cl + OH]+ 1133.2958.
Dichloro[5,10,15,20-tetrakis(4-ethynylphenyl)
porphyrinato]tin(IV) (3). The dichloro[5,10,15,20-
tetrakis((4-trimethylsilyl)ethynylphenyl)porphyrinato]
tin(IV) porphyrin 2 (84.3 mg, 71.0 μmol) was dissolved
in dichloromethane (40 mL). To this was added a solution
of potassium carbonate (1.10 g, 7.97 mmol) in metha-
nol (10 mL) and the mixture was refluxed for 16 h in
the absence of light. After cooling, the solvents were
removed under reduced pressure and the crude solid was
redissolved in dichloromethane (200 mL). The solution
was washed with water (3 × 100 mL) and the organic
layer dried over anhydrous sodium sulfate. The final
product was recovered by filtration and solvent removed
under reduced pressure to give the dichloro[5,10,15,20-
tetrakis(4-ethynylphenyl)porphyrinato]tin(IV) porphy-
rin 3 as a purple crystalline solid (22.1 mg, 29%),
mp>300°C. UV-vis(CH2Cl2):λmax, nm(logε)430(5.84),
561(4.37),602(4.29).1HNMR(300MHz,CDCl3,Me4Si):
δH, ppm 3.37 (4H, s, C≡CH), 7.97 and 8.29 (ABq, 16H,
J = 8.2 Hz, Ph), 9.21 (8H, s, satellites, 4J1H-Sn = 14.8 Hz,
pyrrole-H). 119Sn NMR (149 MHz, CDCl3, Me4Sn): δSn,
ppm -588.77 (Sn). FTIR (KBr): ν, cm-1 3289 (m), 2107
(w), 1498 (m), 1234 (s), 1029 (s), 856 (s), 813 (s). MS
(MALDI): m/z 861.72 (calcd. for [M - 2Cl + 2OH]+
861.53), 828.15 (calcd. for [M - 2Cl]+ 828.13). HR-MS
(FT-ESI): m/z 859.1528 (calcd. for C53H31N4OSn
[M - 2Cl + OCH3]+ 859.1532).
1
551 (4.18), 589 (3.88), 645 (3.86). H NMR (200 MHz,
CDCl3, Me4Si): δH, ppm -2.83 (2H, s, pyrrole-NH), 0.38
(36H, s, Si(CH3)3), 7.79 and 8.16 (16H, ABq, J = 9.0 Hz,
Ph), 8.81 (8H, s, pyrrole-H). FTIR (KBr): ν, cm-1 3313
(w), 2956 (m), 2156 (s), 1497 (s), 1474 (s), 1249 (s), 966
(s), 869 (s). MS (ESI): m/z 1000.53 (calcd. for [M + H]+
999.55).
Activating FTO surface electrodes [38]. The FTO
slides were washed by sonicating in acetone for 5 min
followed by isopropanol for 5 min. The resulting slides
were treated with a solution of H2O2:H2O (30%) and
NH4OH:H2O (25%) at 80 °C for 20 min. The activated
transparent slides were again rinsed with water and dried
under nitrogen prior to use.
Dichloro[5,10,15,20-tetrakis((4-trimethylsilyl)
ethynylphenyl)porphyrinato] tin(IV) (2). The 5,10,
15,20-tetrakis[(4-trimethylsilyl)ethynylphenyl]porphy-
rin 1 (300 mg, 300 μmol) was dissolved in pyridine
(100 mL) and heated to reflux. Tin(II) chloride dihy-
drate (270 mg, 1.20 mmol) was added and the solution
was allowed to reflux in air for 12 h in the absence of
light. After cooling, dichloromethane was evaporated and
water (150 mL) was added. The aqueous layer was then
extracted with dichloromethane (3 × 100 mL). The com-
bined organic extracts were then washed with water (3 ×
100mL)andaqueoushydrochloricacid(1M,2×100mL).
The organic layers were combined, dried over anhydrous
sodium sulfate and filtered. The dichloro[5,10,15,20-
tetrakis((4-trimethylsilyl)ethynylphenyl)porphyrinato]-
tin(IV) porphyrin 2 was collected under reduced pressure
(3-azidopropyl)triethoxysilane (5) [31, 39]. To a
pre-heated solution (60°C) of sodium azide (1.01g,
15.5 mmol) in dimethyl sulfoxide was added (3-chlo-
ropropyl)triethoxysilane (2.00g, 8.33mmol) and stirred
overnight. After cooling, water (100 mL) was added and
the aqueous phase was extracted with diethyl ether (3 ×
100 mL), dried over anhydrous sodium sulfate and fil-
tered. The (3-azidopropyl)triethoxysilane 5 was retrieved
under reduced pressure as a clear yellow oil (1.96 g,
1
95%). H NMR (CDCl3, 200 MHz): δ, ppm 3.86–3.79
(m 2H, CH3CH2Si), 3.26 (t, 2H, N3CH2CH2, J = 7.1 Hz),
Copyright © 2011 World Scientific Publishing Company
J. Porphyrins Phthalocyanines 2011; 15: 80–82